Atlas Trials

The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction

Clinical trial NCT06080802 · UNKNOWN

Trial details

NCT number
NCT06080802
Sponsor
October University for Modern Sciences and Arts
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Heart Failure With Preserved Ejection FractionDiabete Type 2
Start date
2023-11-01
Primary completion
2024-11-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.